Form 4 for AXGN Axogen, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-01 · accession 0000805928-24-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-01 | AXGN | Naor Nir | CFO | A - Grant | — | +300.0K | 300.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-01 | A | A | 300,000 | — | 300,000 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. |